Vis enkel innførsel

dc.contributor.authorØdegård, Rønnaug A.nb_NO
dc.date.accessioned2014-12-19T14:17:54Z
dc.date.available2014-12-19T14:17:54Z
dc.date.created2002-10-19nb_NO
dc.date.issued2002nb_NO
dc.identifier125315nb_NO
dc.identifier.isbn82-471-5129-4nb_NO
dc.identifier.urihttp://hdl.handle.net/11250/263349
dc.description.abstractPreeclampsia is a complex and variable maternal disturbance that ranges from a dramatic onset at early gestation to slowly developing symptoms towards term. Hypertension and renal involvement with proteinuria are cardinal signs, which are often accompanied by fluid retention, blood-clotting dysfunction, and reduced organ perfusion. HELLP (haemolysis, elevated liver enzymes, and low platelet count) syndrome is regarded as a variant of preeclampsia, and the fulminante disease, eclampsia, includes convulsions. Preeclampsia is the main cause of maternal and fetal morbidity and mortality in western countries (1, 2), and in Nordic countries, 17 percent of maternal deaths have been ascribed to preeclampsia (2). Antenatal care in Norway includes on average 12 doctor/midwife consultations per pregnancy (3), and since blood pressure monitoring and urinary testing are main aims of the consultations, preeclampsia is a pregnancy complication that also generates substantial societal costs.nb_NO
dc.languageengnb_NO
dc.publisherDet medisinske fakultetnb_NO
dc.relation.ispartofseriesDissertations at the Faculty of Medicine; 212nb_NO
dc.relation.haspartØdegård, Rønnaug A.; Vatten, Lars J; Nilsen, Stein Tore; Salvesen, Kjell Å; Austgulen, Rigmor. Risk factors and clinical manifestations of pre-eclampsia. British Journal of Obstetrics and Gynaecology. 107(11): 1410-1416, 2000.nb_NO
dc.relation.haspartØdegård, Rønnaug A.; Vatten, Lars J; Nilsen, Stein Tore; Salvesen, Kjell Å; Austgulen, Rigmor. Preeclampsia and fetal growth. Obstetrics & Gynecology. 96(6): 950-955, 2000.nb_NO
dc.relation.haspartØdegård, Rønnaug A.; Vatten, Lars J; Nilsen, Stein Tore; Salvesen, Kjell Å; Vefring, Hege; Austgulen, Rigmor. Umbilical cord plasma interleukin-6 and fetal growth restriction in preeclampsia: a prospective study in Norway. Obstetrics & Gynecology. 98(2): 289-294, 2001.nb_NO
dc.relation.haspartØdegård, Rønnaug A.; Vatten, Lars J; Nilsen, Stein Tore; Salvesen, Kjell Å; Austgulen, Rigmor. Umbilical cord plasma leptin is increased in preeclampsia. American Journal of Obstetrics and Gynecology. 186(3): 427-432, 2002.nb_NO
dc.relation.haspartVatten, Lars J; Ødegård, Rønnaug A.; Nilsen, Stein Tore; Salvesen, Kjell Å; Austgulen, Rigmor. Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight. Obstetrics & Gynecology. 99(1): 85-90, 2002.nb_NO
dc.subjectMolecular biologyen_GB
dc.subjectMedicineen_GB
dc.subjectNATURAL SCIENCES: Biology: Cell and molecular biology: Molecular biologyen_GB
dc.subjectMEDICINE: Dermatology and venerology,clinical genetics, internal medicineen_GB
dc.titlePreeclampsia - maternal risk factors and fetal growthnb_NO
dc.typeDoctoral thesisnb_NO
dc.contributor.departmentNorges teknisk-naturvitenskapelige universitet, Det medisinske fakultet, Institutt for kreftforskning og molekylær medisinnb_NO
dc.description.degreedr.med.nb_NO
dc.description.degreedr.med.en_GB


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel